Search

Search Results

• 

  Genetic predictors of response to treatment of chronic hepatitis C virus infection in patients from southern Italy

  Mario Masarone, Roberta Russo, Antonella Gambale, Concetta Langella, Ferdinando Carlo Sasso, Luca Fontanella, Marco Romano, Achille Iolascon, Marcello Persico

  61-70

  27-02-2014

  https://doi.org/10.4081/itjm.2014.443

  2131

  PDF: 1538

  HTML: 592
• 

  Efficacy of dual therapy in patients >65 years old with alanine transaminase flare during chronic hepatitis C genotype 2

  Elena Garlatti Costa, Michela Ghersetti, Silvia Grazioli, Pietro Casarin

  82-88

  20-03-2015

  https://doi.org/10.4081/itjm.2015.471

  1368

  PDF: 900

  HTML: 283
• 

  Etiology of newly-diagnosed cases of chronic liver disease in Southern Italy: results of a prospective multicentric study

  Antonio Ascione, Mario Masarone, Giovanni Tritto, Carmine Coppola, Cristina Mascolo, Marcello Persico, Giovanbattista Forte, Luca Fontanella, Massimo De Luca, Giovan Giuseppe Di Costanzo, the SCIROCCO Study Group

  176-181

  25-11-2013

  https://doi.org/10.4081/itjm.2013.409

  2107

  PDF: 1325

  HTML: 526
• 

  Use of ursodeoxycholic acid in patients with hypertransaminasemia

  Claudio Puoti, Maria Giuseppa Elmo

  141-147

  18-09-2014

  https://doi.org/10.4081/itjm.2014.426

  1685

  PDF: 1160

  HTML: 1352
• 

  Sex differences in adverse drug reaction and liver disease

  Ombretta Para, Pietro Crispino, Nunzia Barone, Sara Macis, Laura Airasca, Paola Gnerre, Cecilia Politi

  15-22

  20-03-2018

  https://doi.org/10.4081/itjm.2018.893

  2355

  PDF: 1048

  HTML: 496
• 

  The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis

  Sirio Fiorino, Carmela Cursaro, Stefania Lorenzini, Elisabetta Loggi, Lucia Brodosi, Laura Cattani, Andrea Cuppini, Mauro Bernardi, Pietro Andreone

  82-89

  07-03-2013

  https://doi.org/10.4081/itjm.2011.82

  1279

  PDF: 1369
• 

  The management of the patient with acute pancreatitis: from evidence to clinical practice

  Cristina Cenci, Tea Restuccia, Paola Gnerre, Irene Chiti, Laura Betti, Milena Micati, Claudio Tana

  220-245

  11-09-2017

  https://doi.org/10.4081/itjm.2017.748

  3033

  PDF: 1336

  HTML: 1373
• 

  HBsAg loss with HBsAg/anti-HBs seroconversion and non-detectable HCV-RNA in a patient with chronic HBV e-minus/HCV hepatitis treated with two cycles of antiviral therapy

  Antonio Salvio, Maria Varriale, Tito d'Errico, Gennaro De Siena, Mario Visconti

  278-281

  02-01-2012

  https://doi.org/10.4081/itjm.2011.278

  1215

  PDF: 770
• 

  HIV, HCV and SARS-CoV-2: friends or foes? A case report

  Elena Garlatti Costa, Cesare Mazzaro, Alessandro Grembiale, Alessandro Berto, Rita De Rosa, Silvia Grazioli, Maurizio Tonizzo

  24-09-2021

  https://doi.org/10.4081/itjm.2021.1350

  1267

  PDF: 577

  HTML: 8
• 

  HCV carriers with normal aminotransferase levels: normal does not always mean healthy

  Claudio Puoti

  88-92

  30-04-2013

  https://doi.org/10.4081/itjm.2009.88

  1010

  PDF: 1256

• Expert consensus guideline on the diagnosis of type 1 Gaucher disease in adult patients

  Antonio De Vivo, Giovanni Marconi, Nicola Tumedei, Elisa Luicchini, Maria Chiara Finazzi, Ilaria Maria Burgo, Gian Luca Forni, Silvia Linari

  20-06-2024

  https://doi.org/10.4081/itjm.2024.1748

  1954

  PDF: 699

  SUPPLEMENTARY MATERIAL: 151

  HTML: 100

• P28 | Glecaprevir/pibrentasvir in HCV+ Lucanian patients N. Buccianti¹, G. Zaccardo², M. Pace², N. Mecca², C. Vita², D. Ferrante², F. Coviello² | ¹UOC Medicina Interna, Azienda Ospedaliera San Carlo, Potenza, ²UOC Medicina Interna, Azienda Ospedaliera San Carlo, Potenza, Italy

  26-08-2025

  https://doi.org/10.4081/itjm.2025.2220

  137